Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$128.58
At close: Jun 18, 4:02 PM EDT
$128.58
0.000.00%
Pre-Market: Jun 18, 4:02 PM EDT
Comments
Loading...
ICU Medical Analyst Ratings and Price Targets | NASDAQ:ICUI | Benzinga
ICU Medical Inc has a consensus price target of $185.5 based on the ratings of 7 analysts. The high is $216 issued by Keybanc on May 9, 2023. The low is $110 issued by CL King on December 14, 2023. The 3 most-recent analyst ratings were released by Raymond James, Keybanc, and Jefferies on May 9, 2025, April 21, 2025, and December 11, 2024, respectively. With an average price target of $192.67 between Raymond James, Keybanc, and Jefferies, there's an implied 49.84% upside for ICU Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Raymond James
Keybanc
Jefferies
Keybanc
CL King
1calculated from analyst ratings
Analyst Ratings for ICU Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/09/2025 | Buy Now | 45.43% | Raymond James | Jayson Bedford68% | $197 → $187 | Maintains | Strong Buy | Get Alert |
| 04/21/2025 | Buy Now | 48.55% | Keybanc | Tim Rezvan52% | $209 → $191 | Maintains | Overweight | Get Alert |
| 04/08/2025 | Buy Now | — | Needham | Mike Matson56% | — | Reiterates | Hold → Hold | Get Alert |
| 12/11/2024 | Buy Now | 55.55% | Jefferies | Michael Toomey6% | → $200 | Upgrade | Hold → Buy | Get Alert |
| 11/13/2024 | Buy Now | 62.54% | Keybanc | Brett Fishbin49% | $198 → $209 | Maintains | Overweight | Get Alert |
| 11/13/2024 | Buy Now | — | Needham | Mike Matson56% | — | Reiterates | → Hold | Get Alert |
| 10/15/2024 | Buy Now | 53.99% | Keybanc | Brett Fishbin49% | $147 → $198 | Maintains | Overweight | Get Alert |
| 10/14/2024 | Buy Now | 42.32% | Jefferies | Michael Toomey6% | → $183 | Initiates | → Hold | Get Alert |
| 10/10/2024 | Buy Now | — | Needham | Mike Matson56% | — | Reiterates | → Hold | Get Alert |
| 09/12/2024 | Buy Now | 47.77% | Raymond James | Jayson Bedford68% | $158 → $190 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 14.33% | Keybanc | Brett Fishbin49% | $136 → $147 | Maintains | Overweight | Get Alert |
| 08/08/2024 | Buy Now | 22.88% | Raymond James | Jayson Bedford68% | $135 → $158 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | — | Needham | Mike Matson56% | — | Reiterates | → Hold | Get Alert |
| 06/21/2024 | Buy Now | — | Needham | Mike Matson56% | — | Initiates | → Hold | Get Alert |
| 06/17/2024 | Buy Now | 4.99% | Raymond James | Jayson Bedford68% | → $135 | Upgrade | Market Perform → Outperform | Get Alert |
| 02/28/2024 | Buy Now | 5.77% | Keybanc | Brett Fishbin49% | $134 → $136 | Maintains | Overweight | Get Alert |
| 02/06/2024 | Buy Now | 4.22% | Keybanc | Brett Fishbin49% | → $134 | Initiates | → Overweight | Get Alert |
| 12/14/2023 | Buy Now | -14.45% | CL King | Kristen Stewart49% | → $110 | Initiates | → Buy | Get Alert |
| 05/09/2023 | Buy Now | 67.99% | Keybanc | Matthew Mishan52% | $200 → $216 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | — | Raymond James | Jayson Bedford68% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/09/2022 | Buy Now | 47.77% | Raymond James | Jayson Bedford68% | $208 → $190 | Maintains | Outperform | Get Alert |
| 08/09/2022 | Buy Now | 74.99% | Keybanc | Matthew Mishan52% | $230 → $225 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 61.77% | Raymond James | Jayson Bedford68% | $235 → $208 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 78.88% | Keybanc | Matthew Mishan52% | $265 → $230 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for ICU Medical (ICUI) stock?
The latest price target for ICU Medical (NASDAQ:ICUI) was reported by Raymond James on May 9, 2025. The analyst firm set a price target for $187.00 expecting ICUI to rise to within 12 months (a possible 45.43% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ICU Medical (ICUI)?
The latest analyst rating for ICU Medical (NASDAQ:ICUI) was provided by Raymond James, and ICU Medical maintained their strong buy rating.
When was the last upgrade for ICU Medical (ICUI)?
The last upgrade for ICU Medical Inc happened on December 11, 2024 when Jefferies raised their price target to $200. Jefferies previously had a hold for ICU Medical Inc.
When was the last downgrade for ICU Medical (ICUI)?
The last downgrade for ICU Medical Inc happened on November 8, 2022 when Raymond James changed their price target from N/A to N/A for ICU Medical Inc.
When is the next analyst rating going to be posted or updated for ICU Medical (ICUI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ICU Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ICU Medical was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.
Is the Analyst Rating ICU Medical (ICUI) correct?
While ratings are subjective and will change, the latest ICU Medical (ICUI) rating was a maintained with a price target of $197.00 to $187.00. The current price ICU Medical (ICUI) is trading at is $128.58, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
